Wang Hu, Ma Zhiyuan, Cheng Xiaoming, Tuo Biguang, Liu Xuemei, Li Taolang
Department of Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.
Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.
Onco Targets Ther. 2020 Dec 3;13:12427-12441. doi: 10.2147/OTT.S280797. eCollection 2020.
Thyroid cancer is the most common type of endocrine tumor and has shown an increasing annual incidence, especially among women. Patients with thyroid cancer have a good prognosis, with a high five-year survival rate; however, the recurrence rate and disease status of thyroid cancer remain a burden for patients, which compels us to further elucidate the pathogenesis of this disease. Recently, ion transporters have gradually become a hot topic in the field of thyroid gland biology and cancer research. Additionally, alterations in the metabolic state of tumor cells and protein molecules have gradually become the focus of scientific research. This review focuses on the progress in understanding the physiological and pathophysiological roles of ion transporter-mediated metabolism in both the thyroid gland and thyroid cancer. We also hope to shed light on new targets for the treatment and prognosis of thyroid cancer.
甲状腺癌是最常见的内分泌肿瘤类型,且年发病率呈上升趋势,在女性中尤为明显。甲状腺癌患者预后良好,五年生存率较高;然而,甲状腺癌的复发率和疾病状态仍然是患者的负担,这促使我们进一步阐明该疾病的发病机制。近年来,离子转运体逐渐成为甲状腺生物学和癌症研究领域的热点话题。此外,肿瘤细胞代谢状态和蛋白质分子的改变也逐渐成为科研焦点。本综述重点关注离子转运体介导的代谢在甲状腺和甲状腺癌中的生理及病理生理作用的研究进展。我们也希望为甲状腺癌的治疗和预后提供新的靶点。